TCL Archive Funding Opportunity: Leukemia & Lymphoma Society Launches Myeloid Program October 31, 2014
TCL Archive Dasatinib, Nilotinib Show Strong Early Results As Frontline Therapy For CML December 28, 2007
TCL Archive Tesetaxel Showed 20 Percent Response In Second-Line Therapy In Phase IIb Trial January 27, 2012